Loading data for APLM — first visit, this takes a few seconds.
Apollomics Inc. (APLM)
NasdaqCM: APLM
· リアルタイム株価 · USD
23.92
+0.37 (1.57%)
終値時点： Aug 18, 2026, 3:21 PM
Apollomics Inc. (APLM) Stock Price, Analysis & Data
1.57% (1D)
APLMについて
Apollomics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer. The company's products portfolio includes Vebreltinib (APL-101), an oral active, highly selective c-Met inhibitor, which is in Phase 2 clinical trials for treatment of non-small cell lung cancer and other solid tumors with MET dysregulati...
企業情報の全文